HomeCONGRESS

CONGRESS

View Category
Day 2

FACTOR 64: Routine coronary CT angiography in patients at high risk for heart disease.

Article 900 patients with asymptomatic diabetes mellitus were randomized to CT angiography vs. Standard management. Primary end point...
solaci -
Learn More
Day 2

ODYSSEY ALTERNATIVE: Monoclonal antibody alirocumab vs. ezetimibe in patients with statin intolerance

Statin intolerance limits patients’ capacity to reach their LDL goals. This study compared the new drug alirocumab...
solaci -
Learn More
Day 2

Low doses of aspirin for primary prevention in elderly patients with multiple risk factors.

Article The goal of this study was to assess the efficacy of low doses of aspirin (AAS) for...
solaci -
Learn More
Day 2

NONI: Inhaled nitric oxide to reduce reperfusion injury in myocardial infarction

Infarct size is an independent predictor of survival and ventricular function. Several alternatives have been tried to...
solaci -
Learn More
Day 3

IMPI: Prednisolone for tuberculous pericarditis

Tuberculous pericarditis is associated with high morbidity and mortality. This study included 1400 patients with definite or...
solaci -
Learn More
Day 3

IBIS 4: intensive treatment with statins after ST-segment elevation myocardial infarction

Statins may help stabilize the atherosclerotic plaque in acute myocardial infarction. 103 patients who underwent primary angioplasty...
solaci -
Learn More
Day 3

AMIO-CAT: Amiodarone after ablation of atrial fibrillation

Early recurrence of atrial fibrillation after ablation is an experience that discourages patients. The aim of this...
solaci -
Learn More
Day 3

X-Vert: Rivaroxaban in patients with atrial fibrillation undergoing elective cardioversion

This study included 1504 patients with atrial fibrillation and indication for elective electrical cardioversion who were randomized...
solaci -
Learn More